Glimpse Group, Inc. — Director's Dealing 2024

Mar 5, 2024

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Glimpse Group, Inc. (VRAR)
CIK: 0001854445
Period of Report: 2024-02-29

Reporting Person: Rothblum Maydan (Director, CFO and COO)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2024-02-29	Stock Option (Right to Purchase)	$	D	320180	Disposed		Common Stock (320180)	Direct
2024-03-01	Stock Option (Right to Purchase)	$	A	306145	Acquired	2031-03-01	Common Stock (306145)	Direct

Footnotes

F1: Represents the forfeiture of fully vested options to purchase an aggregate of 320,180 shares of common stock granted under the issuer's 2016 equity incentive plan, as amended (the "2016 Plan"), consisting of options to purchase (i) 25,008 shares of common stock and 8,328 shares of common stock granted on September 1, 2019 and September 1, 2020, respectively, with an exercise price of $4.00/share, (ii) 33,333 shares of common stock granted on January 1, 2021 with an exercise price of $4.50/share, (iii) 8 shares of common stock and 3 shares of common stock granted on September 1, 2020 and January 1, 2021, respectively, with exercise prices of $4.00/share and $4.50 /share, respectively, (iv) 2,333 shares of common stock and 1,167 shares of common stock granted on July 1, 2020 and August 1, 2020, with an exercise price of $4.50/share, and (v) 250,000 shares of common stock granted on June 20, 2017, with an exercise price of $2.50.

F2: The options in footnote (1) were to expire 10 years from their respective grant dates.

F3: Mr. Rothblum was granted options to purchase an aggregate of 306,145 shares of the issuer's common stock under the 2016 Plan on March 1, 2023, consisting of (i) options to purchase 18,715 shares of common stock, at an exercise price of $3.00 per share, which options vest on March 1, 2025, (ii) options to purchase 18,715 shares of common stock, at an exercise price of $2.50 per share, which options vest on March 1, 2026, (iii) options to purchase 18,715 shares of common stock, at an exercise price of $2.00 per share, which options vest on March 1, 2027, and (iv) options to purchase 250,000 shares of common stock, at an exercise price of $1.50 per share, which vest monthly over 45 months. All of the foregoing options, other than the option to purchase 250,000 shares of common stock, expire seven years from the grant date. The option to purchase 250,000 shares of common stock expires ten years from the grant date.